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Summary 
Staphylococcal enterotoxin B  (SEB) is a bacterial superantigen  (SAg) that predominantly inter- 
acts with VI38 + T  cells.  In vivo treatment of mice with SEB leads to an initial increase in the 
percentage  of V[~8 +  T  cells,  followed by a  decrease  in the numbers  of these  cells,  eventually 
reaching lower levels than those found before treatment with the SAg. This decrease is due to 
apoptosis of the SEB-responding cells.  In the present study, we use the distinct light scattering 
characteristics ofapoptotic cells to characterize T  cells that are being deleted in response to SEB 
in vivo. We  show  that  dying,  SEB-reactive  T  cells  express high levels of Fas  and  Fas ligand 
(Fas-L), which are implicated in apoptotic cell death. In addition, the B cell marker B220 is up- 
regulated on apoptotic cells. Moreover, we show that the generation of cells with an apoptotic 
phenotype  is severely impaired  in  response  to  SEB  in  functional  Fas-L-deficient  mutant gld 
mice, confirming the role of the Fas pathway in SAg-mediated peripheral deletion in vivo. 
A 
fter  in  vivo  challenge  with  conventional  antigen  or 
with  superantigen  (SAg) l,  peripheral  T  cells undergo 
clonal expansion followed by apoptosis  (1-6).  The expres- 
sion of cell surface markers has been extensively studied in 
resting  and  activated  T  cells,  and  a  substantial  body  of 
knowledge  exists  concerning the  conditions  under  which 
T  cells can undergo  apoptosis. By contrast,  little is known 
about the surface phenotype ofapoptotic cells and their ex- 
pression of molecules that may be implicated in their death. 
One  such  molecule  is  Fas/APO-1  (CD95),  an  integral 
membrane  protein  of the  TNFR  family  (7).  Fas  is  ex- 
pressed on a variety of cell lines and on in vitro-activated T 
cells  (8).  Cross-linking  Fas with  specific  antibodies  results 
in apoptosis  (9).  The ligand for Fas (Fas-L) is a member of 
the  TNF  family,  and  is  expressed  on  certain  cell  lines,  in 
vitro-activated T  cells, and freshly isolated NK cells (7, 10). 
Fas-L can deliver a death signal by triggering Fas (11,  12). 
In this study, we take advantage of the distinct light scatter- 
ing  characteristics  of dying  cells  on  a  flow  cytometer  (re- 
viewed in reference 13) to characterize SAg-specific T  cells 
undergoing  apoptosis.  We  show  that  apoptotic  CD4 +  or 
CD8 + cells retain expression of their TCR  (albeit at lower 
levels)  and  simultaneously  coexpress  the  B  cell-specific 
epitope  of CD45  (13220)  together  with  high  levels  of Fas 
and  Fas-L.  Moreover,  in gld  mice  that  lack  a  functional 
Fas-L (14,  15), SAg-specific T  cells with an apoptotic phe- 
tAbbreviations used in this paper: Fas-L, ligand for Fas; FSC, forward scatter- 
ing; SAg, superantigen; SEB, staphylococcal enterotoxin B; wt, wild type. 
notype are dramatically reduced despite a normal prolifera- 
tive response to SAg in vivo. 
Materials and Methods 
Animals and Treatments.  8-10-wk  old  BALB/c  mice  were 
obtained from Harlan Olac  (Bicester,  UK).  C57BL/6  and con- 
genic  B6SmnC3H-gld  mice  were  purchased  from The Jackson 
Laboratory  (Bar  Harbor,  ME).  The  TCR  V[38.2 transgenic 
mouse line (C57BL6.Tg93/lbm spf) (16) was kindly provided by 
Dr.  H.  Bluethmann  (Hoffman-La R.oche  AG,  Basel,  Switzer- 
land).  These  were  backcrossed  onto  the  BALB/c  background. 
Staphylococcal enterotoxin B  (SEB) (10  p~g) from Toxin Tech- 
nology (Sarasota, FL) was injected into each of the hind footpads. 
Antibodies.  The following directly labeled primary Abs were 
used:  anti-CD4-PE (Becton Dickinson and Co., Palo Alto, CA), 
anti-CD8-PE  (Boehringer  Mannheim,  Mannheim,  Germany); 
anti-V[38  (F23.1)  (17), anti-V13 6 (44.22.1)  (18), anti-CD3 (17A2) 
and (Fab')2 anti-mouse Ig, were directly coupled to FITC in our 
laboratory.  Anti-B220  tricolor  (RA3-6B2)  was purchased  from 
Caltag Laboratories (South San Francisco, CA). Affinity-purified 
polyclonal  rabbit  anti-Fas-L  (PE62)  (19)  and  rabbit  anti-Fas 
(AL59, made against the NH2-terminal 12 residues of mouse Fas, 
Muller,  C.,  and J.  Tschopp,  unpublished  data)  antibodies  were 
revealed by FITC-coupled donkey anti-rabbit Ig (Dianova, Ham- 
burg,  Germany).  Anti-FctL  mAb  (24G2)  was  purchased  from 
Pharmingen (San Diego, CA). 
Flow Cytometric  Analysis and Cell Sorting.  Draining LN ceils were 
stained  with  the  relevant  antibodies  and  either  sorted  using  a 
FACStar  |  Plus  or analyzed on a  FACScan  |  (Becton Dickinson 
and  Co.,  Mountain  View,  CA).  Sorted  cells were  incubated  at 
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Volume 183  February 1996  431-437 37~  for  1 h  (to  allow apoptosis to  occur  [2,  3])  before further 
manipulation. 
Simultaneous staining for BrdU  and DNA  content was  per- 
formed as described (20).  Briefly, cells were fixed in 70% ethanol 
for at least 30 rain and the DNA was partially denatured in 3  N 
HCI, then neutralized with 0.1 M  NazB407. The cells were sub- 
sequently resuspended in 100 Ixl PBS containing 2.5% FCS, and 
added to 200 ILl PBS/FCS containing 3 ~g/ml propidium iodide, 
50 I.Lg/ml RNAse A  (Sigma Chemical Co.,  St.  Louis, MO),  50 
mM Tris base, 50 mM NaC1, and 5  mM EDTA, pH 7.5.  Cells 
were then incubated 5 rain at 37~  and analyzed on a FACScan  | 
equipped with a doublet discrimination module. 
Results 
SAg-specific T  Cells Undergoing Apoptosis  In  Vivo Are For- 
ward Scattering (FSC)  l~  Dying cells diminish in size  before 
disintegrating  and  being  cleared  by  phagocytes  (21).  In- 
deed,  when  undergoing  apoptosis,  thymocytes,  trans- 
formed cells, and cultured splenocytes exhibit low FSC on 
a flow cytometer (13, 22-25), indicating decreased cell size. 
We  have  recently shown  that  in mice  that  were  injected 
with SEB, massive apoptosis of responding VJ38 + T  cells (as 
assessed  by  subdiploid DNA  content)  is  evident 7  d  after 
administration of the SAg, coinciding with and accounting 
for the characteristic  decrease  in the percentage  of these  T 
cells  (26).  Fig.  1  A  shows  that  there  is  an increase  in the 
proportion ofFSC l~  cells in the LN of BALB/c mice that 
were  injected with  SEB  7  d  earlier.  To  confirm  that  the 
FSC  l~  gate  actually contains apoptotic  cells,  we  analyzed 
the DNA  content ofVI38 + T  cells from SEB-treated mice. 
Fig.  1 B  shows that the FSC  l~  but not the FSC  hig~, VJ38 + 
T  cell population contains a  substantial proportion  of sub- 
diploid, apoptotic cells. To investigate whether the conver- 
sion to  an FSC  l~  phenotype  is specific to  SEB-reactive  T 
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Figure 1.  FSC  ]~  population is enriched in SEB-reactive, apoptotic T cells. Mice were injected or not with 10 ~g SEB in each of the hind footpads. 
LN cells were isolated 7 d later, stained, and analyzed by flow cytometry as described in Materials and Methods.  (A) Contour plot showing two distinct 
populations (FSC  high or R1, and FSC  l~  or tk2) based on light scattering parameters. The percentages shown indicate the number of cells in P,.2 as a per- 
centage of the number of cells in R1  +  R.2. (B) DNA content of sorted, FSC  l~  or FSC  high CD4  + VIB8  + cells from SEB-injected mice. (C) Vl38 or VI36 
expression in FSC-gated, CD4  + T cells. These and all subsequent data are representative of at least two independent experiments. 
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Figure 2.  Decreased accumulation of FSC  t~  V[38  + T  cells in SEB- 
treated gld mice. Forward and side scatter profiles of CD4 + V[38  + cells 
from control or SEB-injected wild type C57BL/6  (BL/6) or congenic 
B6SmnC3H-gld (gld) mice were  analyzed by flow cytometry, and the 
percentage ofFSC  j~  cells among total CD4 + V~8 + T cells was calculated 
as described in the legend to Fig. 1. 
cells, analysis of ~PCR  V~  gene  expression in  LN  T  cells 
from naive mice or from mice that received SEB 7 d earlier 
was  performed.  Whereas  V[38 +  T  cells represent  roughly 
30% of FSC  l~  and FSC  high CD4 + LN cells of naive mice, 
the percentage of T  cells bearing this TCR  V[3 segment is 
dramatically increased in the FSC  l~  CD4 + subset from the 
SEB-treated  mice  (Fig.  1  C).  Similar  observations  were 
made in the CD8 +  subset (data not shown).  This increase 
was  specific to  SEB-reactive V[38 +  T  cells since the  pro- 
portion  of SEB-unresponsive  V[36 +  T  cells  was  not  in- 
creased in that same FSC  l~  gate (Fig.  1  C).  Interestingly, 
FSC  l~  T  cells  express  lower  levels  of TCtk  than  their 
FSC  high counterparts  (Fig.  1  C).  This  decrease in fluores- 
cence intensity is unlikely to be simply a  reflection of de- 
creased cell size since other cell surface markers such as B220, 
CD4,  or CD8  are expressed at similar levels in FSC  l~  and 
FSC  high populations (see below). 
SEB-reactive T Cells Undergo Normal Proliferation but Impaired 
Apoptosis in Fas-L-deficient  gld Mice.  To  investigate  whether 
SAg-induced  FSC  l~  cells  are  generated  through  the  Fas 
pathway, we quantitated the accumulation of V[38 + T  cells 
in the FSC  l~  gate from SEB-treated wild type (wt) mice or 
congenic  Fas-L-deficient mice  carrying the gld  mutation. 
As seen in  Fig. 2,  there is a  substantial increase in FSC  l~ 
CD4 + V[38 + T  cells in the wt mice 7 d after injection with 
SEB,  compared to no selective increase in FSC  l~  V[38 + T 
cells from gld mice. 
Next, we investigated whether the decreased accumula- 
tion  of FSC  l~  cells in gld  mice  correlates with  a  lack of 
SEB-mediated deletion in these mice. Fig. 3 A  shows a se- 
verely impaired deletion ofCD4 § V[38 + cells in gld mice as 
late as  14  d  after administration of the  SAg. We have  re- 
cently shown  that proliferation is  a  prerequisite  for  SEB- 
induced T  cell apoptosis (26).  Thus,  it was formally possi- 
ble  that  the  lack  of SEB-mediated  deletion  in gld  mice 
(Figs. 2 and 3 A) is the result of an intrinsic inability of their 
T  cells to proliferate in response to SEB. We addressed this 
issue by quantitating the extent of BrdU incorporation (as a 
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Figure 3.  Normal proliferation but impaired apoptosis in SEB-injected 
gld mice. Wild type and gld mice that were fed BrdU continuously were 
injected with SEB. Their draining LN were dissociated, stained, and ana- 
lyzed by flow cytometry as described above. The percentage of (A) CD4 + 
VI38  + T cells; (B) cells that have incorporated BrdU; and (C) subdiploid 
cells, was assessed  4, 7, and 14 d after SEB injection. The data points on 
day 0 indicate the percentages obtained in control, untreated mice. 
measure  of proliferation)  in  BrdU-fed,  SEB-injected  wt 
and gld mice. We found that LN cells from gld mice incor- 
porated  BrdU  to  the  same  extent  in  response  to  SEB  as 
those  derived from  the  wt  mice  (Fig.  3  B),  and  that  this 
proliferation correlated with a substantial increase in V[38 + 
T  cells (Fig. 3  A).  However,  unlike in  wt  mice  where  a 
drastic  drop  in  the  percentage  of V[38 +  T  cells  and  of 
BrdU +  cells occurred  starting at  day  7  after SEB,  only a 
slight decrease in VI38 + cells could be observed in gld mice 
late in the response to SEB (day 14), correlating with a mi- 
nor and late drop in the percentage of BrdU + cells (Fig. 3, 
A  and  B).  The  impaired deletion of SEB-reactive cells in 
gld mice is due to reduced apoptosis of these cells, which is 
in contrast to wt mice where a peak of subdiploid (apop- 
totic) BrdU + cells can be detected at day 7  (Fig. 3  C). Col- 
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Figure 4.  Fas and Fas-L expression on  FSC  high or FSC  I~  T and B cells. BALB/c mice were injected with SEB, and cells from the draining LN were 
stained 7 d later with the following Abs: anti-CD4 and anti-CD8 (a, b, c,f g, and h) or anti-B220  (d, e, i, and j) in combination  with control Ab (a and f), 
anti-Fas-L (b, g, d, and i), or anti-Fas (c, h, e, and j). (a-e) Cells that were gated on FSC  ugh, while cells inf-j were gated on FSC  1~  CD4/8 indicates cells 
that were stained simultaneously with anti-CD4-PE and anti-CD8-PE at concentrations  that allow discrimination between the two populations based on 
their different fluorescence intensities. The populations with a higher fluorescence intensity are CD8 § cells, and the populations with a lower intensity 
CD4  + cells. 
lectively,  these  data  indicate  that  a  functional  Fas-L  is  re- 
quired for SAg-induced apoptosis to occur in vivo and that 
the generation of most FSC  l~  cells is dependent on this Fas- 
mediated apoptosis. 
Fas and Fas-L Are  Upregulated  on  the  SuoCace of FS~ ~  T 
and B  Cells.  Having established  that  the FSC  ~~  gate pre- 
dominantly  contains  SAg-specific T  cells undergoing  Fas- 
dependent  apoptosis  in vivo, we  studied  the  expression  of 
Fas and Fas-L in FSC  high and FSC  ~~  LN cells isolated from 
SEB-treated  mice.  Using novel antibodies  (19),  we  found 
that  in  FSC  hlgh cells, Fas  is  expressed  at low but  detectable 
levels on CD4 +  and CD8 + T  cells and on B  cells (Fig. 4, c 
and e) whereas Fas-L is expressed constitutively at low lev- 
els on B  cells, but not on T  cells (Fig. 4,  b and d).  By con- 
trast,  Fas  and  Fas-L were  substantially  npregulated  on both 
B  and T  cells in the FSC  ]~  gate (Fig. 4, g-j).  Fas and Fas-L 
staining was not due to FcR binding since identical staining 
was obtained after preincubation with mAb to FcR or with 
an  excess  of normal  mouse  Ig  (not  shown).  Furthermore, 
staining  with  each  of these  Abs  was  specifically  blocked 
with an excess of the relevant peptide  (not shown). 
FSC  ~~  T  Cells  That  Express  High  Levels  of Fas  and  Its 
D'gand A/so Express the B  Cell Marker B220.  Apoptotic T  cells 
accumulating  in  the  liver express  the  B  cell marker  B220 
(6).  Interestingly,  we  also  find B220  expression  on  a  pro- 
portion  of T  cells  in  the  FSC  l~  gate  of LN  from  SEB- 
injected mice (Fig. 5 A). To further characterize these cells, 
the expression ofCD4,  CD8, B220, and either Fas or Fas-L 
was  simultaneously  examined  on  LN  cells  from  SEB- 
treated  mice.  Cells  were  electronically  gated  on  low  for- 
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Figure  5.  Fas  and  Fas-L expression  by 
FSC  I~  cells. LN cells from day 7 SEB mice 
were stained with anti-CD4, anti-CD8, and 
anti-B220,  in combination with either con- 
trol Ab,  anti-Fas,  or anti-Fas-L.  All events 
shown are  gated  on  FSC  I~  (A)  Dot plot 
showing  simultaneous  B220  and  CD4/8 
staining. The population  in each quadrant is 
identified by a roman numeral  and its per- 
centage  is indicated.  (B) Expression  of Fas 
or Fas-L by different subpopulations  identi- 
fied in (A). Shaded histograms, staining with 
anti-Fas or anti-Fas-L  Abs; open histograms, 
staining with normal rabbit Ig. 
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can be distinguished  in the  FSC  l~  gate based on the  ex- 
pression of CD4/8 and B220:  (a) a CD4-8-, B220- popu- 
lation  (quadrant  I), presumably containing  cells  that  have 
lost their membrane integrity since they cannot be stained 
with any of a panel of antibodies (Fig.  5, and not shown); 
(b)  CD4/8 +  (4 +  or  8 +)  B220-  T  cells  (quadrant  II);  (c) 
CD4-8-  B220 +  B  cells  (quadrant  III); and  (d)  CD4/8 +, 
B220 + cells (quadrant IV). These latter cells were T  cells by 
virtue of their expression of CD3, but not surface Ig, and 
were enriched in SEB-responsive VI38 + cells (not shown). 
The expression of Fas  and Fas-L was then examined in 
each of these four populations. As expected, the CD4-8- 
B220- cells were negative for both molecules (Fig.  5 B,/). 
By  contrast,  B220-  T  cells  showed  a  low  staining  with 
anti-Fas-L and an intermediate staining with anti-Fas (Fig. 
5 B, II). B cells exhibited a bimodal (low and high) staining 
for Fas and Fas-L (Fig.  5 B, III).  Interestingly, all B220 + T 
cells expressed high levels of both Fas and its ligand (Fig.  5 
B, IV). 
It is noteworthy  that  FSC  l~  cells  with  the  phenotypes 
described above are also found in LN from untreated mice. 
However,  the  percentage  of B220 +  LN T  cells  increases 
significantly  in  the  FSC  l~  gate  upon  treatment  of mice 
with SEB (26% in untreated mice compared to 44% in day 
7 SEB-treated mice), and this increase is due to a selective 
accumulation ofSEB-reactive V]38 + T  cells (data not shown). 
Discussion 
In  this  study,  we  have  phenotypically  characterized  a 
population of apoptotic T  cells generated during the course 
of the immune response to the bacterial SAg SEB in vivo. 
These cells,  readily identifiable by their low forward scat- 
tering  on  a  flow cytometer,  a  hallmark of apoptotic  cells 
(13),  express the CD4 or CD8 coreceptors, reduced levels 
of TCR, the B cell marker B220, and high levels of the apop- 
tosis-associated molecules, Fas and Fas-L. This novel phe- 
notype is presumably the product ofa Fas-dependent, apop- 
totic process since the generation of these cells is impaired 
in Fas-L-deficient gld mice. 
In  a  recent  report,  the  surface  phenotype  of cultured 
thymocytes undergoing apoptosis was studied using a new 
method (TUNEL) that detects DNA strand breaks (25).  It 
was  shown  that  all  apoptotic  (TUNEL  +)  cells  were  also 
FSC  l~  and vice versa, further validating the use of FSC  l~ 
as a marker of apoptosis. An advantage of FSC as an apop- 
tosis marker is that (unlike the fluorescent markers used to 
identify apoptotic cells)  it does not occupy a fluorescence 
channel on the flow cytometer, thereby allowing the use of 
an  additional  marker  in  multiparameter  cell  phenotypic 
analysis of apoptotic cells. 
Previous reports have shown impaired T  cell deletion in 
response to  SAgs in  Fas-defective Ipr mice  (27,  28)  or to 
antigenic peptide in TCR  transgenic mice carrying the lpr 
mutation (29).  We show here that this finding also applies 
to Fas-L-deficient gld mice immunized with SEB. We have 
recently shown that SEB-mediated T  cell apoptosis has to 
be preceded by proliferation  (26).  The fact that V[38  +  T 
cells from gld mice respond to SEB by undergoing prolifer- 
ation  in  vivo  rules  out  the  possibility  that  the  impaired 
apoptosis in these mice may be due to some intrinsic prolif- 
erative  defect.  Rather,  we  show  direct  evidence  for  re- 
duced  apoptosis in  the  proliferating cell population.  This 
finding is of relevance in light of the conflicting results re- 
garding the susceptibility of lpr T  cells to apoptotic cell death 
(30-33). 
Since activation of T  cells is a prerequisite for apoptosis 
in several experimental systems (26,  34-38), it is not unrea- 
sonable to  expect that  some  markers found  on  apoptotic 
cells  (such as B220,  Fas,  or Fas-L) would be expressed on 
their putative precursors, i.e., viable activated T  cells. B220 
has been reported  to be widely expressed on activated T 
cells  (6).  We consistently find a small proportion (10%)  of 
B220 +  T  cells  among  FSC  high LN blast  cells  from SEB- 
primed mice.  Furthermore,  the  majority of these  FSC  high 
B220 §  T  cell blasts  upregulate their expression of Fas and 
Fas-L  (not  shown),  suggesting  that  they  may represent  a 
transitional population that will eventually become FSC  I~ 
B220 + Fas  high Fas-L  high (apoptotic) cells.  The accumulation 
ofFSChig  h B220 + T  cells in lpr orgld mice defective in Fas- 
dependent  apoptosis  (reviewed in  reference  8)  is likewise 
consistent with the hypothesis that B220 upregulation on T 
cells represents an intermediate stage in the process leading 
to Fas-mediated T  cell death. 
Ifupregulation of Fas-L is required for induction ofapop- 
tosis (7, 39, 40), and since B220 + T  cells are the predonfi- 
nant LN cell population  that  expresses high  levels  of this 
molecule, it follows that B220 + T  cells are likely candidates 
to be involved in SAg-induced apoptosis. Since these same 
cells  (in addition to some B cells) express high levels of Fas 
(also shown to be required for apoptosis [41]),  three non- 
mutually  exclusive  mechanisms  of Fas-dependent  killing 
can be envisaged (42,  43):  (a) B220 + T  cells kill each other 
(fractricidal killing)  (44);  (b) B220 + T  cells  kill themselves 
in  an  autocrine  fashion  (suicidal  killing)  (45,  46);  or  (c) 
B220 § T  cells are killed by B  cells.  This latter possibility is 
consistent with the fact that a proportion of FSC  l~  B  cells 
express high levels of Fas-L and that activated B  cells from 
normal, but not gld  mice,  can kill Fas-bearing target cells 
under  certain  conditions  (Hahne,  M.,  T.  Renno,  M. 
Schroeter, M.  Irmler, L. French,  T. Bornand,  H.R. Mac- 
Donald, and J. Tschopp, manuscript submitted for publica- 
tion). The mechanism of B cell activation by SEB in vivo is 
not known but may involve either  cognate T-B  interac- 
tion or direct activation via MHC class II cross-linking (re- 
viewed in reference 47). 
In summary, we have analyzed the surface phenotype of 
cells undergoing apoptosis in response to SEB in vivo. We 
show that apoptotic, SEB-reactive T  cells express the B220 
marker  and  high  levels  of  Fas  and  Fas-L.  These  data 
strongly implicate the Fas pathway in SAg-induced apopto- 
sis in vivo; however,  the actual mechanism of Fas-depen- 
dent cell death remains to be elucidated. 
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